> ## Content Index
> Fetch the complete content index at: https://members.americanhealthintel.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# RadNet Q2 2026 earnings show 25% revenue growth, new $250 million acquisition facility
- URL: https://members.americanhealthintel.com/2026-08-11-serviceline/
- Published: 2026-08-11T21:06:46.000Z
- Updated: 2026-08-11T21:06:46.000Z
- Description: Plus: CY2027 fee schedule code-level swings: CT angiography chest up 149%, CT upper extremity down 15%. The day's rules, money, and enforcement, sourced and tiered below.
- Author: American Health Intel

Plus: CY2027 fee schedule code-level swings: CT angiography chest up 149%, CT upper extremity down 15%. The day's rules, money, and enforcement, sourced and tiered below.

| American Health Intel Rules · Money · Medicine · Decoded daily The Service Line Tuesday, August 11, 2026 RadNet Q2 2026 earnings show 25% revenue growth, new $250 million acquisition facility Plus: CY2027 fee schedule code-level swings: CT angiography chest up 149%, CT upper extremity down 15%. The day's rules, money, and enforcement, sourced and tiered below. ![](https://americanhealthintel.com/email/pulse-divider.png) Earnings Confidence: High RadNet, the largest publicly traded chain of outpatient imaging centers in the US, just posted a 25% revenue jump and opened a new $250 million credit line to buy more imaging centers and AI companies. Second-quarter revenue hit $622.7 million. AI-specific revenue grew 136% and annual recurring revenue nearly doubled to $105.5 million, filed with the SEC August 10, 2026. Why it matters Bigger picture: the largest imaging chain in the country now has more cash and cheaper debt to buy up competitors, a sign of consolidation ahead in local imaging markets. Watch whether more independent groups get bought in your area. Sources: [SEC](https://www.sec.gov/Archives/edgar/data/0000790526/000162828026055338/rdnt-20260630.htm?ref=members.americanhealthintel.com) · [Stocktitan](https://www.stocktitan.net/news/RDNT/rad-net-reports-second-quarter-financial-results-with-record-5l9ok226ni8s.html?ref=members.americanhealthintel.com) · [Investing](https://www.investing.com/news/transcripts/earnings-call-transcript-radnet-tops-q2-2026-estimates-shares-rise-61-93CH-4849907?ref=members.americanhealthintel.com) Rule Confidence: Medium Medicare's proposed 2027 doctor pay rule cuts the base rate again, but radiology's own specialty societies say the code-level math tells a very different story than the headline cut. CT angiography of the chest is proposed to rise 149% to $83.09, while CT of the upper extremity without contrast is proposed to fall 15%. Comments close September 14, 2026. Why it matters The headline "Medicare cut doctor pay again" hides big winners and losers underneath; if you get imaging done, access to certain scans may shift as practices adjust to code-level reimbursement changes. Sources: [Sirweb](https://www.sirweb.org/publications/news/sir-mpfs-cy-2027-proposed-rule-summary-and-impact-analysis/?ref=members.americanhealthintel.com) · [Auntminnie](https://www.auntminnie.com/practice-management/administration/economics/article/15830122/acr-issues-initial-summary-of-2027-mpfs-proposed-rule?ref=members.americanhealthintel.com) Also today Mt. Baker Imaging ransomware settlement claims deadline August 19, hearing August 21 [Read](https://americanhealthintel.com/editions/2026-08-11-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#mt-baker-imaging-ransomware-settlement) Anthem BCBS Georgia signs in-network deal with Radiology Partners affiliate Northside Radiology [Read](https://americanhealthintel.com/editions/2026-08-11-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#anthem-georgia-northside-radiology-in-network-2026) GE HealthCare's Invenia ABUS Prime wins FDA clearance for faster dense-breast screening [Read](https://americanhealthintel.com/editions/2026-08-11-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#ge-healthcare-invenia-abus-prime-2026) Imaging interpretation turnaround time up 27% in one year, Neiman HPI finds [Read](https://americanhealthintel.com/editions/2026-08-11-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#neiman-imaging-turnaround-time-2026) 483Records$31.9BEnforcement22Deadlines136Rules [Read this issue + the trackers](https://americanhealthintel.com/editions/2026-08-11-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) Pick your field on the site and every story tells you what it means for you. Reply to this email and tell us what you want covered. We read everything. We show our work. We score our own calls. [Track record](https://americanhealthintel.com/ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Calendar](https://americanhealthintel.com/calendar/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Enforcement](https://americanhealthintel.com/enforcement/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [X](https://x.com/amhealthintel?ref=members.americanhealthintel.com) · [LinkedIn](https://www.linkedin.com/company/american-health-intel?ref=members.americanhealthintel.com) News and analysis, not legal, medical, coding, or investment advice.You subscribed at americanhealthintel.com · [Unsubscribe](%%{unsubscribe%5Furl}%%) |
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |